Clinical Research Directory
Browse clinical research sites, groups, and studies.
Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
Sponsor: Cedars-Sinai Medical Center
Summary
The primary purpose of this study is to evaluate the safety and efficacy of ex vivo machine perfusion with staged implantation of kidney allografts during combined heart/kidney transplantation.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-04-07
Completion Date
2035-02-28
Last Updated
2025-06-03
Healthy Volunteers
No
Interventions
Planned delayed implantation of kidney allograft with ex vivo machine perfusion kidney preservation.
During combined heart and kidney transplantation, heart and kidney allografts may be implanted during a single operative event, or with delayed kidney implantation in a second operative event. Timing of the delay is often determined by recipient stability and kidney availability; however, clinicians must balance recipient factors with accumulating cold ischemic time of the kidney allograft. This study uses hypothermic oxygenated machine perfusion to reduce ischemic injury to the kidney allograft and allow for improved recipient stability with planned delayed implantation of the kidney graft. Delays will allow for at least 6 hours of hypothermic oxygenated machine perfusion prior to implantation.
Locations (1)
Cedars-Sinai Medical Center
Los Angeles, California, United States